Zynex: Abusive Pricing Model Unsustainable (NASDAQ:ZYXI)

By A Mystery Man Writer

September 19,2024

Zynex shares are up ~100x since late 2016 as retail investors buy into a story of rapid revenue and earnings growth.

Zynex: A Fact Finding Mission (NASDAQ:ZYXI)

Zynex: Seems An Odd Short Target (NASDAQ:ZYXI)

Is Zynex (NASDAQ:ZYXI) Using Too Much Debt? - Simply Wall St News

Zynex (NASDAQ:ZYXI) shareholders have earned a 27% CAGR over the

Is Zynex, Inc.'s (NASDAQ:ZYXI) Recent Stock Performance Tethered

Zynex: UnitedHealthcare Terminating Contract – An Undisclosed Loss

ZYXI: A case study - by Adu Subramanian

I Am A Bearish Bull On Zynex; It's Complicated (NASDAQ:ZYXI

Zynex Medical

Zynerba Pharma (NASDAQ:ZYNE) Skyrockets 3x on Acquisition by

The Zynex Party Has Much Further To Go (NASDAQ:ZYXI)

Zynex: Abusive Pricing Model Unsustainable (NASDAQ:ZYXI)

Zynex: Turnaround Nears End – UnitedHealthcare Cuts TENS

Zynex: Deteriorating Fundamentals And Signs Of Reimbursement

Zynex Medical